Your browser doesn't support javascript.
loading
[Retrospective study on the efficacy and safety of low dose apatinib in reversing chemotherapy resistance in sarcoma].
Ye, T; Yuan, S Y; Fan, L; Feng, L W; Chen, Y T; Chen, J.
Afiliación
  • Ye T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Yuan SY; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Fan L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Feng LW; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Chen YT; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Chen J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhonghua Yi Xue Za Zhi ; 102(31): 2435-2440, 2022 Aug 23.
Article en Zh | MEDLINE | ID: mdl-36000372
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Neoplasias Óseas / Osteosarcoma / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Neoplasias Óseas / Osteosarcoma / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China